Skip to main content
. 2017 Apr 8;8(23):37409–37422. doi: 10.18632/oncotarget.16964

Table 1. Patient characteristics of the PREVAIL study.

Patient number Age Sex Study completion
01 65 Female Completed study
02 77 Female Completed study
03 75 Male Excluded due to hearing impairment grade 3*
04 71 Female Completed study

* Since a rare side-effect of valproate is hearing impairment, patients with impaired hearing were excluded from the study.